Jonathan Sicsic1, Nathalie Pelletier-Fleury2, Nora Moumjid3. 1. Centre Léon Bérard, Cancer Environment Team, Lyon, France; CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France; Health Services and Performance Research (HESPER EA 7425), Lyon, France. Electronic address: jonathan.sicsic@inserm.fr. 2. CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France. 3. Centre Léon Bérard, Cancer Environment Team, Lyon, France; Health Services and Performance Research (HESPER EA 7425), Lyon, France; University Claude Bernard, Lyon, France.
Abstract
BACKGROUND: Over the past decade, the benefits and harms balance of breast cancer (BC) screening has been widely debated. OBJECTIVES: To elicit women's trade-offs between the benefits and harms of BC screening and to analyze the main determinants of these trade-offs. METHODS: A discrete-choice experiment with seven attributes depicting BC screening programs including varying levels of BC mortality, overdiagnosis, and false-positive result was used. Eight hundred twelve women aged 40 to 74 years with no personal history of BC recruited by a survey institute and representative of the French general population (age, socioeconomic level, and geographical location) completed the discrete-choice experiment. Preference heterogeneity was investigated using generalized multinomial logit models from which individual trade-offs were derived, and their main determinants were assessed using generalized linear models. Screening acceptance rates under various benefits and harms ratios were simulated on the basis of the distribution of individual preferences. RESULTS: The women would be willing to accept on average 14.1 overdiagnosis cases (median = 9.6) and 47.8 false-positive results (median = 27.2) to avoid one BC-related death. After accounting for preference heterogeneity, less than 50% of women would be willing to accept 10 overdiagnosis cases for one BC-related death avoided. Screening acceptance rates were higher among women with higher socioeconomic level and lower among women with poor health. CONCLUSIONS: Women are sensitive to both the benefits and the harms of BC screening and their preferences are highly heterogeneous. Our study provides useful results for public health authorities and clinicians willing to improve their recommendations of BC screening on the basis of women's preferences.
BACKGROUND: Over the past decade, the benefits and harms balance of breast cancer (BC) screening has been widely debated. OBJECTIVES: To elicit women's trade-offs between the benefits and harms of BC screening and to analyze the main determinants of these trade-offs. METHODS: A discrete-choice experiment with seven attributes depicting BC screening programs including varying levels of BC mortality, overdiagnosis, and false-positive result was used. Eight hundred twelve women aged 40 to 74 years with no personal history of BC recruited by a survey institute and representative of the French general population (age, socioeconomic level, and geographical location) completed the discrete-choice experiment. Preference heterogeneity was investigated using generalized multinomial logit models from which individual trade-offs were derived, and their main determinants were assessed using generalized linear models. Screening acceptance rates under various benefits and harms ratios were simulated on the basis of the distribution of individual preferences. RESULTS: The women would be willing to accept on average 14.1 overdiagnosis cases (median = 9.6) and 47.8 false-positive results (median = 27.2) to avoid one BC-related death. After accounting for preference heterogeneity, less than 50% of women would be willing to accept 10 overdiagnosis cases for one BC-related death avoided. Screening acceptance rates were higher among women with higher socioeconomic level and lower among women with poor health. CONCLUSIONS:Women are sensitive to both the benefits and the harms of BC screening and their preferences are highly heterogeneous. Our study provides useful results for public health authorities and clinicians willing to improve their recommendations of BC screening on the basis of women's preferences.
Keywords:
benefits and harms balance; breast cancer screening; discrete-choice experiment; overdiagnosis; preference heterogeneity; willingness to accept
Authors: Lise Mørkved Helsingen; Linan Zeng; Reed Alexander Siemieniuk; Lyubov Lytvyn; Per Olav Vandvik; Thomas Agoritsas; Michael Bretthauer; Gordon Guyatt Journal: BMJ Open Date: 2020-12-02 Impact factor: 2.692
Authors: Ash Kieran Clift; David Dodwell; Simon Lord; Stavros Petrou; Sir Michael Brady; Gary S Collins; Julia Hippisley-Cox Journal: Br J Cancer Date: 2021-10-26 Impact factor: 9.075